CLINICAL_TRIALS
trial_result
· 2025-08-12
Clinical Trial Update: ADJUnct Semaglutide Treatment in Type 1 Diabetes [Phase 2]
Summary
A Phase 2 trial evaluating adjunct semaglutide for treatment in Type 1 diabetes mellitus with obesity has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Viral N. Shah | Conditions: Type 1 Diabetes, Obesity | Phase 2 | Status: COMPLETED | Results posted: 2025-08-12